Adlai Nortye Ltd., a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies,...
MediLink Therapeutics (Suzhou) Co., Ltd (MediLink) has announced completion of a $70million Series B financing. Thi...
GenieBiome (G-NiiB), a biotechnology spin-off of The Chinese University of Hong Kong (CUHK), announces the launch of G-N...
Hong Kong Baptist University (HKBU) has established a transdisciplinary team of experts and supporting personnel to...
Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase I multi-r...
IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer ther...
Asieris Pharmaceuticals, a global innovative biopharma company specializing in discovering and developing innovativ...
Pulnovo Medical Limited, a globally recognized OTM innovative platform, recently announced the appointment of Jessie Lia...
Chinese firm Gan & Lee Pharmaceuticals has announced that the first subject has been dosed in our Phase I, double-bl...
The MIKADO group, a translational team at the University of Zurich (UZH) focused on generating evidence-driven...
Researchers from the School of Public Health, LKS Faculty of Medicine of The University of Hong Kong (HKUMed), in collab...
SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, has announced the CE (Conformit&...
Akeso, Inc., a biopharmaceutical company dedicated to the development of innovative antibody drugs, has announced that t...
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabl...
Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platf...
AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announc...
111, Inc., a leading tech-enabled healthcare platform company in China, has signed a strategic cooperation agreement on ...
China based I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercializa...
